Springvest

Volare is a food technology company that upcycles industrial food waste into sustainable protein, oil, and fertilizer ingredients, including insect-derived proteins and lipids produced from black soldier fly larvae, using proprietary technology. The company aims to replace nature-destroying inputs such as fishmeal from wild catch, soy, and palm oil in animal feeds and the chemical industry, helping processors meet climate and nature goals by converting side-streams back into the food chain as protein and lipid ingredients.

Solar Foods is a food‑tech company founded in 2017 and headquartered in Lappeenranta, Finland. It develops a patented hydrogen‑fermentation platform that converts electricity into hydrogen, which is then combined with carbon dioxide, water, vitamins, and minerals to feed hydrogen‑oxidizing microbes. The resulting single‑cell biomass is processed into Solein, a protein‑rich powder that serves as a sustainable, nutritionally complete substitute for animal‑derived proteins. The company focuses on commercializing this technology to produce food raw materials that can replace animal‑based foods while reducing environmental impact.

Founded in Finland in 2011, Desentum is a biopharmaceutical company dedicated to developing innovative allergy vaccines. Its unique approach involves designing vaccines that switch the immune system's response from hypersensitivity to tolerance, aiming to provide long-term relief for patients suffering from allergies.

Solar Foods is a food‑tech company founded in 2017 and headquartered in Lappeenranta, Finland. It develops a patented hydrogen‑fermentation platform that converts electricity into hydrogen, which is then combined with carbon dioxide, water, vitamins, and minerals to feed hydrogen‑oxidizing microbes. The resulting single‑cell biomass is processed into Solein, a protein‑rich powder that serves as a sustainable, nutritionally complete substitute for animal‑derived proteins. The company focuses on commercializing this technology to produce food raw materials that can replace animal‑based foods while reducing environmental impact.

Kuva Space is a company focused on enhancing life on Earth through its extensive constellation of nanosatellites equipped with advanced hyperspectral imaging technology. By utilizing its GREEN DATA® platform, Kuva Space addresses critical global challenges such as climate change, disaster response, and food security. The company provides actionable data and insights that support sustainable management of natural resources, enabling clients to optimize agricultural practices, improve land use, and make informed investment and financial decisions. Additionally, its technology allows for the measurement of regional carbon sequestration rates, prevention of large-scale forest fires, and detection of gas leaks, all facilitated by an integrated artificial intelligence platform.

MedicubeX is a pioneering company in the field of preventive healthcare, focused on developing autonomous self-measurement and telehealth eHealth Stations. As the first advanced health kiosk in the Nordics, MedicubeX provides users with access to clinical-grade medical check-ups regardless of their location. Its eHealth Stations are designed to measure vital signs and assess risk factors, particularly concerning cardiovascular health. These stations facilitate healthcare automation, allowing users to conduct health check-ups in just a few minutes. With features such as automated umbilical venous catheter disinfection and options for privacy during remote appointments, MedicubeX aims to deliver scalable and accessible solutions for monitoring health status and enhancing preventive care.

Cerenion is a medical device company dedicated to improving outcomes for patients suffering from brain injuries due to emergencies like stroke or seizures. They offer C-Trend, an AI-based technology enabling rapid and reliable brain monitoring in hospital emergency and intensive care units.

Founded in Finland in 2011, Desentum is a biopharmaceutical company dedicated to developing innovative allergy vaccines. Its unique approach involves designing vaccines that switch the immune system's response from hypersensitivity to tolerance, aiming to provide long-term relief for patients suffering from allergies.

Rocsole develops and markets industrial process monitoring and control technology based on 3D tomographic imaging and optics. Its sensors use electrical capacitance tomography to create real-time 3D images of multiphase flows, enabling continuous monitoring of liquid levels, entrained air, sand, and interfaces. The company supplies hardware sensors, software analytics, and engineering services aimed at process optimization, piloting, and electronics and optical component design and manufacturing. It serves energy production and manufacturing sectors, including oil and gas, food, chemical, pulp and paper, and other process industries. Rocsole provides in-line and on-tank inspection capabilities and supports optical and mechanical design, prototyping, and assembly, as well as lab testing and optical measurements. By delivering continuous visibility into fluid systems, Rocsole helps reduce unplanned downtime and improve efficiency and sustainability.

Bioretec Ltd. is a Finnish medical device company that specializes in the development, manufacturing, and marketing of bioabsorbable and bioactive surgical implants. These implants are designed for use in orthopedic, trauma, and sports medicine surgeries, catering to both pediatric and adult patients. Bioretec's products are recognized for their safety and reliability and are utilized globally. The company is committed to advancing materials and products suitable for high-load-bearing clinical applications. Notable brands associated with Bioretec include RemeOs, Activa IM-N, ActivaPi, and ActivaScrew.

Verto Analytics Inc. specializes in audience cross-platform measurement solutions that track consumer behavior across various devices, applications, and platforms. The company operates a passive metering panel that collects longitudinal data on user interactions, providing insights into daily usage patterns, content consumption, and demographics. Its offerings include Verto App Watch, which analyzes mobile application usage, and Verto Watch, which aids device vendors and carriers in understanding consumer behavior related to their products. Verto Content Watch helps publishers assess their reach and market dynamics, while Verto Index focuses on cross-device usage of travel websites. Additionally, Verto provides tools for measuring user retention and engagement, as well as custom research services. Established in 2013 and headquartered in New York City, Verto Analytics also has offices in San Francisco, London, and Helsinki, enhancing its ability to deliver comprehensive insights into the evolving landscape of digital media consumption.

Convion Ltd., established in 2012 and located in Espoo, Finland, specializes in the development and manufacturing of solid oxide fuel cell systems for power generation and hydrogen production. The company's technology facilitates the efficient conversion of various fuels into electricity and steam, promoting sustainable energy solutions. Convion's modular fuel cell systems are designed for flexibility, allowing them to operate with different fuel types and catering to both industrial and commercial applications. By focusing on high-efficiency energy conversion, Convion aims to enhance energy independence and security while providing reliable and operationally flexible solutions in the power generation market.

Mobidiag is a Finnish-French biotechnology company specializing in the development and marketing of molecular diagnostic solutions aimed at detecting gastrointestinal infections, antimicrobial resistance, healthcare-associated infections, respiratory infections, and sepsis. The company utilizes established technologies such as real-time polymerase chain reaction (qPCR) and microarray to create a wide array of diagnostic tests and automated platforms. These solutions are designed to be fast, reliable, and cost-effective, catering to laboratories of various sizes. Mobidiag's offerings enable the detection of a majority of clinically relevant pathogens, including bacteria, parasites, and viruses, as well as important markers for antibiotic resistance, thereby enhancing diagnostic capabilities in hospitals, laboratories, and clinics.

Finbiosoft is a company dedicated to creating software solutions that enhance the efficiency of clinical laboratories and diagnostic companies. Its flagship product, Validation Manager™, is a web-based platform designed to streamline the validation and verification processes for diagnostic tests. By automating and standardizing data handling, Validation Manager™ reduces the time and potential errors associated with these tasks. The software supports laboratory professionals and test manufacturers in conducting accurate evaluations, ultimately improving the quality of diagnostics. Finbiosoft's approach enables scientists to implement the most effective diagnostic tools with minimal resource expenditure.

Springvest is a crowdfunding platform based in Helsinki, Finland, established in 2012. It aims to streamline the financing process for promising Finnish growth companies, allowing them to focus on their business rather than spending excessive time on fundraising. By connecting these companies with investors seeking higher potential opportunities, Springvest facilitates financing rounds that empower businesses to capitalize on their ideas more quickly and effectively. The platform encourages Finnish investors to engage with local growth companies, fostering a community that supports innovation and potential success in the Finnish market.

Ductor is a Finnish biotechnology company focused on addressing climate change and food sustainability challenges through innovative technology. It has developed proprietary and patented methods for biologically producing ammonia and phosphates from recycled materials. This technology can be integrated into various applications, including algae farming, to enhance nutrient supply and energy production. Ductor has achieved a significant milestone by initiating industrial-scale production, with its first implementation designed to augment existing biogas facilities, thereby improving their economic viability. The company aims to provide sustainable organic fertilizers and renewable energy, supporting farmers and food producers in maintaining healthy soils and promoting ecological farming practices.

Founded in Finland in 2011, Desentum is a biopharmaceutical company dedicated to developing innovative allergy vaccines. Its unique approach involves designing vaccines that switch the immune system's response from hypersensitivity to tolerance, aiming to provide long-term relief for patients suffering from allergies.

The mariPOC® test system allows a multi-analytical result from one patient sample with one analysis. The test system provides central laboratory-level accuracy for patient-centered diagnostics. The reliability of the results is verified by automatic testing of the test system.

Ukkoverkot Ltd is a Finnish mobile data operator specializing in the production and marketing of wireless telecommunication services. The company operates a 450 MHz 4G LTE mobile data network that spans the entirety of Finland, catering primarily to businesses, authorities, and other demanding user groups. Ukkoverkot does not provide voice or SMS services, instead focusing solely on mobile data solutions. In addition to its nationwide offerings, the company delivers high-speed mobile network solutions designed for both continuous and temporary coverage needs.

Volare is a food technology company that upcycles industrial food waste into sustainable protein, oil, and fertilizer ingredients, including insect-derived proteins and lipids produced from black soldier fly larvae, using proprietary technology. The company aims to replace nature-destroying inputs such as fishmeal from wild catch, soy, and palm oil in animal feeds and the chemical industry, helping processors meet climate and nature goals by converting side-streams back into the food chain as protein and lipid ingredients.

CurifyLabs is a Finnish healthtech company that develops 3D printing solutions for manufacturing personalized medicines in pharmacies and hospitals. Its automated on-demand manufacturing concept, the Pharma Kit, and printable pharmaceutical inks enable personalized mass customization of medicines, aiming to improve patient safety and treatment efficacy while lowering costs. The company offers a platform that automates and streamlines drug compounding and drug technology, enabling on-site 3D printing of personalized medicines in pharmacies. This approach supports sustainable manufacturing and better fitting treatments for individual patients.